Daniel Portal

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding
    Daniel Portal
    Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard University, Boston, MA 02215, USA
    Proc Natl Acad Sci U S A 108:7808-13. 2011
  2. ncbi Genome-wide analysis of Epstein-Barr virus Rta DNA binding
    Andreas M F Heilmann
    The Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Virol 86:5151-64. 2012

Collaborators

  • Andreas M F Heilmann
  • Eric Johannsen
  • Michael A Calderwood
  • Yong Lu

Detail Information

Publications2

  1. ncbi EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding
    Daniel Portal
    Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard University, Boston, MA 02215, USA
    Proc Natl Acad Sci U S A 108:7808-13. 2011
    ..These data strongly support a model in which EBNA2 association with NCoR-deficient RBPJ enhances transcription and EBNALP dismisses NCoR and RBPJ repressive complexes from enhancers to coactivate hes1 and arglu1 but not cd21 or cd23...
  2. ncbi Genome-wide analysis of Epstein-Barr virus Rta DNA binding
    Andreas M F Heilmann
    The Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Virol 86:5151-64. 2012
    ..Our results represent the first characterization of Rta binding to the EBV genome during replication, identify previously unknown RREs, such as one in BALF5p, and highlight the complexity of EBV late gene promoter activation by Rta...